Linden Thomas Advisory Services’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,597	Closed	-$578K	–	396
2023 Q2	$578K	Buy	19,597 +372	+2%	+$11K	0.13%	289
2023 Q1	$443K	Buy	19,225 +961	+5%	+$22.1K	0.11%	301
2022 Q4	$508K	Buy	+18,264	New	+$508K	0.14%	247